MAAT INDEX

CLAIM #2914 · Abbott Laboratories (ABT) · 2022Q2 earnings call · Jul 19, 2022 · due Dec 31, 2022

So we feel confident in that floor number. And we believe that there's opportunities here for upside to that.

Robert Ford · CEO

CANNOT_DETERMINE
resolved by a revision, graded at the moved level · official band 5 percent
Committed
So we feel confident in that floor number. And we believe that there's opportunities here for upside to that.
Reported
We increased our full year adjusted earnings per share guidance to $5.17 to $5.23, which is more than 10% higher than the initial guidance flow we provided back in January.

Verify independently

SEC filings for ABT · Claim quote is verbatim from the 2022Q2 earnings call.